Literature DB >> 10639444

Immunogenicity of the B monomer of Escherichia coli heat-labile toxin expressed on the surface of Streptococcus gordonii.

S Ricci1, D Medaglini, C M Rush, A Marcello, S Peppoloni, R Manganelli, G Palú, G Pozzi.   

Abstract

The B monomer of the Escherichia coli heat-labile toxin (LTB) was expressed on the surface of the human oral commensal bacterium Streptococcus gordonii. Recombinant bacteria expressing LTB were used to immunize BALB/c mice subcutaneously and intragastrically. The LTB monomer expressed on the streptococcal surface proved to be highly immunogenic, as LTB-specific immunoglobulin G (IgG) serum titers of 140,000 were induced after systemic immunization. Most significantly, these antibodies were capable of neutralizing the enterotoxin in a cell neutralization assay. Following mucosal delivery, antigen-specific IgA antibodies were found in feces and antigen-specific IgG antibodies were found in sera. Analysis of serum IgG subclasses showed a clear predominance of IgG1 when recombinant bacteria were inoculated subcutaneously, while a prevalence of IgG2a was observed upon intragastric delivery, suggesting, in this case, the recruitment of a Th1 type of immune response.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10639444      PMCID: PMC97203          DOI: 10.1128/IAI.68.2.760-766.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  51 in total

1.  Antigenicity and immunogenicity of the V3 domain of HIV type 1 glycoprotein 120 expressed on the surface of Streptococcus gordonii.

Authors:  M R Oggioni; D Medaglini; L Romano; F Peruzzi; T Maggi; L Lozzi; L Bracci; M Zazzi; F Manca; P E Valensin; G Pozzi
Journal:  AIDS Res Hum Retroviruses       Date:  1999-03-20       Impact factor: 2.205

2.  Bacteria-induced neo-biosynthesis, stabilization, and surface expression of functional class I molecules in mouse dendritic cells.

Authors:  M Rescigno; S Citterio; C Thèry; M Rittig; D Medaglini; G Pozzi; S Amigorena; P Ricciardi-Castagnoli
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

3.  Commensal bacteria as vectors for mucosal vaccines against sexually transmitted diseases: vaginal colonization with recombinant streptococci induces local and systemic antibodies in mice.

Authors:  D Medaglini; C M Rush; P Sestini; G Pozzi
Journal:  Vaccine       Date:  1997 Aug-Sep       Impact factor: 3.641

4.  Intestinal antibody responses after immunisation with cholera B subunit.

Authors:  A M Svennerholm; D A Sack; J Holmgren; P K Bardhan
Journal:  Lancet       Date:  1982-02-06       Impact factor: 79.321

5.  Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin.

Authors:  C O Elson; W Ealding
Journal:  J Immunol       Date:  1984-06       Impact factor: 5.422

6.  Cholera toxin B subunit as a carrier protein to stimulate a mucosal immune response.

Authors:  S J McKenzie; J F Halsey
Journal:  J Immunol       Date:  1984-10       Impact factor: 5.422

Review 7.  Actions of cholera toxin and the prevention and treatment of cholera.

Authors:  J Holmgren
Journal:  Nature       Date:  1981-07-30       Impact factor: 49.962

8.  Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato.

Authors:  C O Tacket; H S Mason; G Losonsky; J D Clements; M M Levine; C J Arntzen
Journal:  Nat Med       Date:  1998-05       Impact factor: 53.440

9.  Oral immunization with the B subunit of the heat-labile enterotoxin of Escherichia coli induces early Th1 and late Th2 cytokine expression in Peyer's patches.

Authors:  I Nakagawa; I Takahashi; H Kiyono; J R McGhee; S Hamada
Journal:  J Infect Dis       Date:  1996-06       Impact factor: 5.226

10.  Mucosal immunoadjuvant activity of recombinant Escherichia coli heat-labile enterotoxin and its B subunit: induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with influenza virus surface antigen.

Authors:  W R Verweij; L de Haan; M Holtrop; E Agsteribbe; R Brands; G J van Scharrenburg; J Wilschut
Journal:  Vaccine       Date:  1998-12       Impact factor: 3.641

View more
  14 in total

1.  In vivo activation of naive CD4+ T cells in nasal mucosa-associated lymphoid tissue following intranasal immunization with recombinant Streptococcus gordonii.

Authors:  Donata Medaglini; Annalisa Ciabattini; Anna Maria Cuppone; Caterina Costa; Susanna Ricci; Massimo Costalonga; Gianni Pozzi
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

2.  Surface display of recombinant proteins on Bacillus subtilis spores.

Authors:  R Isticato; G Cangiano; H T Tran; A Ciabattini; D Medaglini; M R Oggioni; M De Felice; G Pozzi; E Ricca
Journal:  J Bacteriol       Date:  2001-11       Impact factor: 3.490

3.  Oral immunization with recombinant Streptococcus gordonii expressing porphyromonas gingivalis FimA domains.

Authors:  A Sharma; K Honma; R T Evans; D E Hruby; R J Genco
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

4.  Stimulation of human monocytes with the gram-positive vaccine vector Streptococcus gordonii.

Authors:  Annalisa Ciabattini; Anna Maria Cuppone; Rita Pulimeno; Francesco Iannelli; Gianni Pozzi; Donata Medaglini
Journal:  Clin Vaccine Immunol       Date:  2006-09

5.  Clinical and microbiological responses of volunteers to combined intranasal and oral inoculation with a Streptococcus gordonii carrier strain intended for future use as a group A streptococcus vaccine.

Authors:  Karen L Kotloff; Steven S Wasserman; Kevin F Jones; Sofie Livio; Dennis E Hruby; Christine A Franke; Vincent A Fischetti
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

6.  Expression of a functional single-chain variable-fragment antibody against complement receptor 1 in Streptococcus gordonii.

Authors:  Jennifer B Knight; Scott A Halperin; Kenneth A West; Song F Lee
Journal:  Clin Vaccine Immunol       Date:  2008-04-02

7.  Primary activation of antigen-specific naive CD4+ and CD8+ T cells following intranasal vaccination with recombinant bacteria.

Authors:  Annalisa Ciabattini; Elena Pettini; Peter Andersen; Gianni Pozzi; Donata Medaglini
Journal:  Infect Immun       Date:  2008-10-06       Impact factor: 3.441

8.  Protective Immunity Against Enterotoxigenic Escherichia coli by Oral Vaccination of Engineered Lactococcus lactis.

Authors:  Homa Ahmadi Rouzbahani; Seyed Latif Mousavi Gargari; Shahram Nazarian; Sajad Abdollahi
Journal:  Curr Microbiol       Date:  2021-07-15       Impact factor: 2.188

9.  Prime-boost strategies in mucosal immunization affect local IgA production and the type of th response.

Authors:  Fabio Fiorino; Elena Pettini; Gianni Pozzi; Donata Medaglini; Annalisa Ciabattini
Journal:  Front Immunol       Date:  2013-05-29       Impact factor: 7.561

10.  In vivo mucosal delivery of bioactive human interleukin 1 receptor antagonist produced by Streptococcus gordonii.

Authors:  Susanna Ricci; Giovanni Macchia; Paolo Ruggiero; Tiziana Maggi; Paola Bossù; Li Xu; Donata Medaglini; Aldo Tagliabue; Lennart Hammarström; Gianni Pozzi; Diana Boraschi
Journal:  BMC Biotechnol       Date:  2003-09-17       Impact factor: 2.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.